Brain Tau Imaging: Food and Drug Administration Approval of ¹⁸F-Flortaucipir Injection

J Nucl Med. 2020 Oct;61(10):1411-1412. doi: 10.2967/jnumed.120.252254. Epub 2020 Aug 4.

Authors

Venkata S Mattay¹, Anthony F Fotenos¹, Charles J Ganley², Libero Marzella³

Affiliations

¹ Division of Imaging and Radiation Medicine, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland; and.
² Office of Specialty Medicine, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
³ Division of Imaging and Radiation Medicine, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland; and libero.marzella@fda.hhs.gov.

PMID: 32753388
DOI: 10.2967/jnumed.120.252254

No abstract available

Publication types

Editorial

MeSH terms

Alzheimer Disease / diagnostic imaging*
Brain / diagnostic imaging*
Carbolines*
Drug Approval*
Humans
Positron-Emission Tomography / methods*
United States
United States Food and Drug Administration
tau Proteins / metabolism*

Substances

Carbolines
tau Proteins
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole